Literature DB >> 22105843

Threshold-based prediction of the coagulation zone in sequential temperature mapping in MR-guided radiofrequency ablation of liver tumours.

Hansjörg Rempp1, Rüdiger Hoffmann, Jörg Roland, Alexandra Buck, Antje Kickhefel, Claus D Claussen, Philippe L Pereira, Fritz Schick, Stephan Clasen.   

Abstract

OBJECTIVE: To evaluate different cut-off temperature levels for a threshold-based prediction of the coagulation zone in magnetic resonance (MR)-guided radiofrequency (RF) ablation of liver tumours.
METHODS: Temperature-sensitive measurements were acquired during RF ablation of 24 patients with primary (6) and secondary liver lesions (18) using a wide-bore 1.5 T MR sytem and compared with the post-interventional coagulation zone. Temperature measurements using the proton resonance frequency shift method were performed directly subsequent to energy application. The temperature maps were registered on the contrast-enhanced follow-up MR images acquired 4 weeks after treatment. Areas with temperatures above 50°, 55° and 60°C were segmented and compared with the coagulation zones. Sensitivity and positive predictive value were calculated.
RESULTS: No major complications occurred and all tumours were completely treated. No tumour recurrence was observed at the follow-up examination after 4 weeks. Two patients with secondary liver lesions showed local tumour recurrence after 4 and 7 months. The 60°C threshold level achieved the highest positive predictive value (87.7 ± 9.9) and the best prediction of the coagulation zone.
CONCLUSIONS: For a threshold-based prediction of the coagulation zone, the 60°C cut-off level achieved the best prediction of the coagulation zone among the tested levels. KEY POINTS: • Temperature monitoring can be used to survey MR-guided radiofrequency ablation • The developing ablation zone can be estimated based on post-interventional temperature measurements • A 60°C threshold level can be used to predict the ablation zone • The 50°C and 55°C temperature zones tend to overestimate the ablation zone.

Entities:  

Mesh:

Year:  2011        PMID: 22105843     DOI: 10.1007/s00330-011-2335-8

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  30 in total

1.  Magnetic resonance thermometry for predicting thermal damage: an application of interstitial laser coagulation in an in vivo canine prostate model.

Authors:  R D Peters; E Chan; J Trachtenberg; S Jothy; L Kapusta; W Kucharczyk; R M Henkelman
Journal:  Magn Reson Med       Date:  2000-12       Impact factor: 4.668

2.  Sonographically observed echogenic response during intraoperative radiofrequency ablation of cirrhotic livers: pathologic correlation.

Authors:  John R Leyendecker; Gerald D Dodd; Glenn A Halff; Victor A McCoy; Dacia H Napier; Linda G Hubbard; Kedar N Chintapalli; Shailendra Chopra; W Kenneth Washburn; Robert M Esterl; Francisco G Cigarroa; Ruth E Kohlmeier; Francis E Sharkey
Journal:  AJR Am J Roentgenol       Date:  2002-05       Impact factor: 3.959

3.  Study of laser ablation in the in vivo rabbit brain with MR thermometry.

Authors:  Lili Chen; Janaka P Wansapura; Gary Heit; Kim Butts
Journal:  J Magn Reson Imaging       Date:  2002-08       Impact factor: 4.813

4.  Radio-frequency-induced thermal lesions: subacute magnetic resonance appearance and histological correlation.

Authors:  Roee S Lazebnik; Michael S Breen; Maryann Fitzmaurice; Sherif G Nour; Jonathan S Lewin; David L Wilson
Journal:  J Magn Reson Imaging       Date:  2003-10       Impact factor: 4.813

Review 5.  Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors.

Authors:  Stefaan Mulier; Yicheng Ni; Jacques Jamart; Theo Ruers; Guy Marchal; Luc Michel
Journal:  Ann Surg       Date:  2005-08       Impact factor: 12.969

Review 6.  MR thermometry for monitoring tumor ablation.

Authors:  Baudouin Denis de Senneville; Charles Mougenot; Bruno Quesson; Iulius Dragonu; Nicolas Grenier; Chrit T W Moonen
Journal:  Eur Radiol       Date:  2007-05-22       Impact factor: 5.315

7.  Radiofrequency ablation of small liver malignancies under magnetic resonance guidance: progress in targeting and preliminary observations with temperature monitoring.

Authors:  Sylvain Terraz; Alexandru Cernicanu; Matthieu Lepetit-Coiffé; Magalie Viallon; Rares Salomir; Gilles Mentha; Christoph D Becker
Journal:  Eur Radiol       Date:  2009-09-16       Impact factor: 5.315

8.  Diffusion-weighted MRI of advanced hepatocellular carcinoma during sorafenib treatment: initial results.

Authors:  Christina Schraml; Nina F Schwenzer; Petros Martirosian; Michael Bitzer; Ulrich Lauer; Claus D Claussen; Marius Horger
Journal:  AJR Am J Roentgenol       Date:  2009-10       Impact factor: 3.959

Review 9.  Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update.

Authors:  Stefaan Mulier; Theo Ruers; Jacques Jamart; Luc Michel; Guy Marchal; Yicheng Ni
Journal:  Dig Surg       Date:  2009-02-12       Impact factor: 2.588

10.  Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study.

Authors:  Tito Livraghi; Luigi Solbiati; M Franca Meloni; G Scott Gazelle; Elkan F Halpern; S Nahum Goldberg
Journal:  Radiology       Date:  2003-02       Impact factor: 11.105

View more
  9 in total

Review 1.  Advances in local ablation of malignant liver lesions.

Authors:  Robert M Eisele
Journal:  World J Gastroenterol       Date:  2016-04-21       Impact factor: 5.742

2.  MR-guided radiofrequency ablation using a wide-bore 1.5-T MR system: clinical results of 213 treated liver lesions.

Authors:  Hansjörg Rempp; Lorenz Waibel; Rüdiger Hoffmann; Claus D Claussen; Philippe L Pereira; Stephan Clasen
Journal:  Eur Radiol       Date:  2012-04-18       Impact factor: 5.315

3.  CEM43°C thermal dose thresholds: a potential guide for magnetic resonance radiofrequency exposure levels?

Authors:  Gerard C van Rhoon; Theodoros Samaras; Pavel S Yarmolenko; Mark W Dewhirst; Esra Neufeld; Niels Kuster
Journal:  Eur Radiol       Date:  2013-04-04       Impact factor: 5.315

4.  Optimized Echo Decorrelation Imaging Feedback for Bulk Ultrasound Ablation Control.

Authors:  Mohamed A Abbass; Allison-Joy Garbo; Neeraja Mahalingam; Jakob K Killin; T Douglas Mast
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2018-06-14       Impact factor: 2.725

5.  Feature-based automated segmentation of ablation zones by fuzzy c-mean clustering during low-dose computed tomography.

Authors:  Po-Hung Wu; Mariajose Bedoya; Jim White; Christopher L Brace
Journal:  Med Phys       Date:  2020-12-18       Impact factor: 4.071

6.  PRFS-based MR thermometry versus an alternative T1 magnitude method--comparative performance predicting thermally induced necrosis in hepatic tumor ablation.

Authors:  Christian Rosenberg; Antje Kickhefel; Birger Mensel; Tilman Pickartz; Ralf Puls; Joerg Roland; Norbert Hosten
Journal:  PLoS One       Date:  2013-10-24       Impact factor: 3.240

7.  Comparison study of reconstruction algorithms for volumetric necrosis maps from 2D multi-slice GRE thermometry images.

Authors:  Julian Alpers; Bennet Hensen; Maximilian Rötzer; Daniel L Reimert; Thomas Gerlach; Ralf Vick; Marcel Gutberlet; Frank Wacker; Christian Hansen
Journal:  Sci Rep       Date:  2022-07-07       Impact factor: 4.996

Review 8.  Optimizing Loco Regional Management of Oligometastatic Colorectal Cancer: Technical Aspects and Biomarkers, Two Sides of the Same Coin.

Authors:  Giovanni Mauri; Lorenzo Monfardini; Andrea Garnero; Maria Giulia Zampino; Franco Orsi; Paolo Della Vigna; Guido Bonomo; Gianluca Maria Varano; Marco Busso; Carlo Gazzera; Paolo Fonio; Andrea Veltri; Marco Calandri
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

9.  Combination therapy with local radiofrequency ablation and systemic vaccine enhances antitumor immunity and mediates local and distal tumor regression.

Authors:  Sofia R Gameiro; Jack P Higgins; Matthew R Dreher; David L Woods; Goutham Reddy; Bradford J Wood; Chandan Guha; James W Hodge
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.